Agenus (AGEN) Other Accumulated Expenses (2010 - 2026)
Agenus' (AGEN) quarterly Other Accumulated Expenses came in at $514000.0 in Q1 2026, down 89.76% year-on-year from $5.0 million in Q1 2025, and down 2.84% quarter-over-quarter from $529000.0 in Q4 2025.
Agenus (AGEN) Other Accumulated Expenses (2010 - 2026) Analysis & Trends
Agenus' Other Accumulated Expenses history runs 17 years deep, the most recent figure standing at $514000.0 for Q1 2026.
- On a quarterly basis, Other Accumulated Expenses fell 89.76% year-over-year to $514000.0 in Q1 2026; TTM through Mar 2026 was $514000.0, a 89.76% decrease from a year earlier, with the FY2025 full-year figure at $529000.0, down 93.23% from the prior year.
- Other Accumulated Expenses fell to $514000.0 in Q1 2026 per AGEN's latest filing, from $529000.0 in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $14.0 million in Q1 2024 and bottomed at $514000.0 in Q1 2026.
- The 5-year median for Other Accumulated Expenses is $7.3 million (2024), against an average of $7.7 million.
- Across the five-year window, Other Accumulated Expenses soared 260.16% in 2023 and slumped 93.23% in 2025, its largest moves.
- Year by year, Other Accumulated Expenses stood at $11.5 million in 2022, then climbed by 21.45% to $13.9 million in 2023, then tumbled by 43.82% to $7.8 million in 2024, then slumped by 93.23% to $529000.0 in 2025, then retreated by 2.84% to $514000.0 in 2026.
- Per Business Quant, the three latest AGEN Other Accumulated Expenses figures stand at $514000.0 (Q1 2026), $529000.0 (Q4 2025), and $7.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,899.61 Bn | 65,899.33 Bn | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - |
| 4 | BeOne Medicines | 472.68 Bn | 467.89 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.24 Bn | 114.99 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.08 Bn | 61.33 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.46 Bn | 62.46 Bn | - |
| 8 | Argenx Se | 55.93 Bn | 50.75 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.59 Bn | 34.58 Bn | 959.66 Mn |
| 10 | Agenus | 230.49 Mn | 195.50 Mn | 33.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 514,000.00 |
| Dec 31, 2025 | 529,000.00 |
| Sep 30, 2025 | 7.36 Mn |
| Jun 30, 2025 | 3.89 Mn |
| Mar 31, 2025 | 5.02 Mn |
| Dec 31, 2024 | 7.82 Mn |
| Sep 30, 2024 | 7.29 Mn |
| Jun 30, 2024 | 7.07 Mn |
| Mar 31, 2024 | 14.03 Mn |
| Dec 31, 2023 | 13.92 Mn |
| Sep 30, 2023 | 13.42 Mn |
| Jun 30, 2023 | 13.27 Mn |
| Mar 31, 2023 | 12.94 Mn |
| Dec 31, 2022 | 11.46 Mn |
| Sep 30, 2022 | 3.73 Mn |
| Jun 30, 2022 | 3.81 Mn |
| Mar 31, 2022 | 4.61 Mn |
| Dec 31, 2021 | 6.55 Mn |
| Sep 30, 2021 | 6.78 Mn |
| Jun 30, 2021 | 5.36 Mn |